|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:RANGRF-LRP5 (FusionGDB2 ID:HG29098TG4041) |
Fusion Gene Summary for RANGRF-LRP5 |
Fusion gene summary |
Fusion gene information | Fusion gene name: RANGRF-LRP5 | Fusion gene ID: hg29098tg4041 | Hgene | Tgene | Gene symbol | RANGRF | LRP5 | Gene ID | 29098 | 4041 |
Gene name | RAN guanine nucleotide release factor | LDL receptor related protein 5 | |
Synonyms | HSPC165|HSPC236|MOG1|RANGNRF | BMND1|EVR1|EVR4|HBM|LR3|LRP-5|LRP-7|LRP7|OPPG|OPS|OPTA1|PCLD4|VBCH2 | |
Cytomap | ('RANGRF')('LRP5') 17p13.1 | 11q13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | ran guanine nucleotide release factorMOG1 homologran-binding protein MOG1 | low-density lipoprotein receptor-related protein 5low density lipoprotein receptor-related protein 5low density lipoprotein receptor-related protein 7 | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000226105, ENST00000407006, ENST00000439238, ENST00000580434, | ||
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 17 X 23 X 10=3910 |
# samples | 1 | 27 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(27/3910*10)=-3.85613729514388 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: RANGRF [Title/Abstract] AND LRP5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | RANGRF(8192732)-LRP5(68177382), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | RANGRF-LRP5 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RANGRF-LRP5 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RANGRF-LRP5 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. RANGRF-LRP5 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | RANGRF | GO:0003254 | regulation of membrane depolarization | 18184654 |
Hgene | RANGRF | GO:0042391 | regulation of membrane potential | 18184654 |
Hgene | RANGRF | GO:1902305 | regulation of sodium ion transmembrane transport | 18184654 |
Hgene | RANGRF | GO:2000010 | positive regulation of protein localization to cell surface | 18184654 |
Hgene | RANGRF | GO:2000649 | regulation of sodium ion transmembrane transporter activity | 18184654 |
Tgene | LRP5 | GO:0008284 | positive regulation of cell proliferation | 9790987 |
Tgene | LRP5 | GO:0045840 | positive regulation of mitotic nuclear division | 9790987 |
Tgene | LRP5 | GO:0045893 | positive regulation of transcription, DNA-templated | 15035989|17955262 |
Tgene | LRP5 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 12857724 |
Tgene | LRP5 | GO:0060070 | canonical Wnt signaling pathway | 11029007|12121999|12857724|15908424|24706814|25920554 |
Fusion gene breakpoints across RANGRF (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across LRP5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-A2-A0CT-01A | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + |
Top |
Fusion Gene ORF analysis for RANGRF-LRP5 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000226105 | ENST00000529481 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + |
5CDS-intron | ENST00000407006 | ENST00000529481 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + |
5CDS-intron | ENST00000439238 | ENST00000529481 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + |
5CDS-intron | ENST00000580434 | ENST00000529481 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + |
In-frame | ENST00000226105 | ENST00000294304 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + |
In-frame | ENST00000407006 | ENST00000294304 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + |
In-frame | ENST00000439238 | ENST00000294304 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + |
In-frame | ENST00000580434 | ENST00000294304 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000226105 | RANGRF | chr17 | 8192732 | + | ENST00000294304 | LRP5 | chr11 | 68177382 | + | 3605 | 643 | 292 | 3399 | 1035 |
ENST00000407006 | RANGRF | chr17 | 8192732 | + | ENST00000294304 | LRP5 | chr11 | 68177382 | + | 3448 | 486 | 135 | 3242 | 1035 |
ENST00000580434 | RANGRF | chr17 | 8192732 | + | ENST00000294304 | LRP5 | chr11 | 68177382 | + | 3431 | 469 | 118 | 3225 | 1035 |
ENST00000439238 | RANGRF | chr17 | 8192732 | + | ENST00000294304 | LRP5 | chr11 | 68177382 | + | 3945 | 983 | 1001 | 3739 | 912 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000226105 | ENST00000294304 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + | 0.001065145 | 0.9989348 |
ENST00000407006 | ENST00000294304 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + | 0.000953515 | 0.9990465 |
ENST00000580434 | ENST00000294304 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + | 0.00097145 | 0.99902856 |
ENST00000439238 | ENST00000294304 | RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177382 | + | 0.001282271 | 0.9987178 |
Top |
Fusion Genomic Features for RANGRF-LRP5 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177381 | + | 6.98E-10 | 1 |
RANGRF | chr17 | 8192732 | + | LRP5 | chr11 | 68177381 | + | 6.98E-10 | 1 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for RANGRF-LRP5 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:8192732/chr11:68177382) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1495_1610 | 697 | 1616.0 | Compositional bias | Note=Pro-rich | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1213_1254 | 697 | 1616.0 | Domain | Note=EGF-like 4 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1258_1296 | 697 | 1616.0 | Domain | LDL-receptor class A 1 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1297_1333 | 697 | 1616.0 | Domain | LDL-receptor class A 2 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1335_1371 | 697 | 1616.0 | Domain | LDL-receptor class A 3 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 902_942 | 697 | 1616.0 | Domain | Note=EGF-like 3 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1500_1506 | 697 | 1616.0 | Motif | Note=PPPSP motif A | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1538_1545 | 697 | 1616.0 | Motif | Note=PPPSP motif B | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1574_1581 | 697 | 1616.0 | Motif | Note=PPPSP motif C | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1591_1596 | 697 | 1616.0 | Motif | Note=PPPSP motif D | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1605_1612 | 697 | 1616.0 | Motif | Note=PPPSP motif E | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 945_1212 | 697 | 1616.0 | Region | Note=Beta-propeller 4 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1036_1078 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 17 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1079_1123 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 18 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1124_1164 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 19 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1165_1207 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 20 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 730_772 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 12 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 773_815 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 13 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 816_855 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 14 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 819_822 | 697 | 1616.0 | Repeat | Note=YWTD 10 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 856_898 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 15 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 859_862 | 697 | 1616.0 | Repeat | Note=YWTD 11 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 989_1035 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 16 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1408_1615 | 697 | 1616.0 | Topological domain | Cytoplasmic | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 1385_1407 | 697 | 1616.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 295_337 | 697 | 1616.0 | Domain | Note=EGF-like 1 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 601_641 | 697 | 1616.0 | Domain | Note=EGF-like 2 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 32_288 | 697 | 1616.0 | Region | Note=Beta-propeller 1 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 341_602 | 697 | 1616.0 | Region | Note=Beta-propeller 2 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 644_903 | 697 | 1616.0 | Region | Note=Beta-propeller 3 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 120_162 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 2 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 123_126 | 697 | 1616.0 | Repeat | Note=YWTD 2 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 163_206 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 3 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 166_169 | 697 | 1616.0 | Repeat | Note=YWTD 3 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 207_247 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 4 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 248_290 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 5 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 251_254 | 697 | 1616.0 | Repeat | Note=YWTD 4 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 385_427 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 6 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 388_391 | 697 | 1616.0 | Repeat | Note=YWTD 5 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 428_470 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 7 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 431_434 | 697 | 1616.0 | Repeat | Note=YWTD 6 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 471_514 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 8 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 474_477 | 697 | 1616.0 | Repeat | Note=YWTD 7 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 515_557 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 9 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 558_600 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 10 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 559_562 | 697 | 1616.0 | Repeat | Note=YWTD 8 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 687_729 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 11 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 690_693 | 697 | 1616.0 | Repeat | Note=YWTD 9 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 75_119 | 697 | 1616.0 | Repeat | Note=LDL-receptor class B 1 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 78_81 | 697 | 1616.0 | Repeat | Note=YWTD 1 | |
Tgene | LRP5 | chr17:8192732 | chr11:68177382 | ENST00000294304 | 8 | 23 | 32_1384 | 697 | 1616.0 | Topological domain | Extracellular |
Top |
Fusion Gene Sequence for RANGRF-LRP5 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>72123_72123_1_RANGRF-LRP5_RANGRF_chr17_8192732_ENST00000226105_LRP5_chr11_68177382_ENST00000294304_length(transcript)=3605nt_BP=643nt GGGGGCGACATAGACCCTAACCCTAAGTCCAACCCCAAGGCAGACCCCACCGTCCCGCCAGGCGCACTCCTAAGAGCGCGGCTTCCGGAG CAAAGCCGCTGACCCCCGCCCCCAGGGTCTTGGCGCCGATTGGCCAACGAGAGCGCAGGGCGGAGCCAAATCTTAAAGGATCCGGGAGCT AAGCCAGACCCGGGTGGCGGTGGCAGCTGCGAAACCCAGGGAGCCGATGCCACGTGACCCAATGTGGACTTCTTTTAAACCTTTCTAATG CCCATAACCCAGCCTCAGACCCATGGAGCCCACGAGAGACTGCCCGCTGTTCGGGGGCGCCTTTTCCGCCATCCTCCCCATGGGGGCCAT TGACGTAAGCGACCTCCGACCGGTCCCGGACAATCAAGAAGTTTTCTGCCATCCCGTGACGGACCAGAGCCTGATAGTGGAACTTCTCGA GCTGCAGGCCCACGTACGGGGCGAAGCGGCTGCGCGGTACCACTTTGAGGATGTTGGTGGCGTGCAGGGGGCTAGGGCTGTCCATGTGGA GTCTGTTCAGCCTCTCAGTTTGGAGAACCTGGCCCTGAGGGGCCGCTGTCAAGAAGCCTGGGTCCTCTCTGGCAAGCAGCAGATAGCTAA GGAAAACCAGCAGACCATCAGCCGCGCCTTCATGAACGGGAGCTCGGTGGAGCACGTGGTGGAGTTTGGCCTTGACTACCCCGAGGGCAT GGCCGTTGACTGGATGGGCAAGAACCTCTACTGGGCCGACACTGGGACCAACAGAATCGAAGTGGCGCGGCTGGACGGGCAGTTCCGGCA AGTCCTCGTGTGGAGGGACTTGGACAACCCGAGGTCGCTGGCCCTGGATCCCACCAAGGGCTACATCTACTGGACCGAGTGGGGCGGCAA GCCGAGGATCGTGCGGGCCTTCATGGACGGGACCAACTGCATGACGCTGGTGGACAAGGTGGGCCGGGCCAACGACCTCACCATTGACTA CGCTGACCAGCGCCTCTACTGGACCGACCTGGACACCAACATGATCGAGTCGTCCAACATGCTGGGTCAGGAGCGGGTCGTGATTGCCGA CGATCTCCCGCACCCGTTCGGTCTGACGCAGTACAGCGATTATATCTACTGGACAGACTGGAATCTGCACAGCATTGAGCGGGCCGACAA GACTAGCGGCCGGAACCGCACCCTCATCCAGGGCCACCTGGACTTCGTGATGGACATCCTGGTGTTCCACTCCTCCCGCCAGGATGGCCT CAATGACTGTATGCACAACAACGGGCAGTGTGGGCAGCTGTGCCTTGCCATCCCCGGCGGCCACCGCTGCGGCTGCGCCTCACACTACAC CCTGGACCCCAGCAGCCGCAACTGCAGCCCGCCCACCACCTTCTTGCTGTTCAGCCAGAAATCTGCCATCAGTCGGATGATCCCGGACGA CCAGCACAGCCCGGATCTCATCCTGCCCCTGCATGGACTGAGGAACGTCAAAGCCATCGACTATGACCCACTGGACAAGTTCATCTACTG GGTGGATGGGCGCCAGAACATCAAGCGAGCCAAGGACGACGGGACCCAGCCCTTTGTTTTGACCTCTCTGAGCCAAGGCCAAAACCCAGA CAGGCAGCCCCACGACCTCAGCATCGACATCTACAGCCGGACACTGTTCTGGACGTGCGAGGCCACCAATACCATCAACGTCCACAGGCT GAGCGGGGAAGCCATGGGGGTGGTGCTGCGTGGGGACCGCGACAAGCCCAGGGCCATCGTCGTCAACGCGGAGCGAGGGTACCTGTACTT CACCAACATGCAGGACCGGGCAGCCAAGATCGAACGCGCAGCCCTGGACGGCACCGAGCGCGAGGTCCTCTTCACCACCGGCCTCATCCG CCCTGTGGCCCTGGTGGTGGACAACACACTGGGCAAGCTGTTCTGGGTGGACGCGGACCTGAAGCGCATTGAGAGCTGTGACCTGTCAGG GGCCAACCGCCTGACCCTGGAGGACGCCAACATCGTGCAGCCTCTGGGCCTGACCATCCTTGGCAAGCATCTCTACTGGATCGACCGCCA GCAGCAGATGATCGAGCGTGTGGAGAAGACCACCGGGGACAAGCGGACTCGCATCCAGGGCCGTGTCGCCCACCTCACTGGCATCCATGC AGTGGAGGAAGTCAGCCTGGAGGAGTTCTCAGCCCACCCATGTGCCCGTGACAATGGTGGCTGCTCCCACATCTGTATTGCCAAGGGTGA TGGGACACCACGGTGCTCATGCCCAGTCCACCTCGTGCTCCTGCAGAACCTGCTGACCTGTGGAGAGCCGCCCACCTGCTCCCCGGACCA GTTTGCATGTGCCACAGGGGAGATCGACTGTATCCCCGGGGCCTGGCGCTGTGACGGCTTTCCCGAGTGCGATGACCAGAGCGACGAGGA GGGCTGCCCCGTGTGCTCCGCCGCCCAGTTCCCCTGCGCGCGGGGTCAGTGTGTGGACCTGCGCCTGCGCTGCGACGGCGAGGCAGACTG TCAGGACCGCTCAGACGAGGCGGACTGTGACGCCATCTGCCTGCCCAACCAGTTCCGGTGTGCGAGCGGCCAGTGTGTCCTCATCAAACA GCAGTGCGACTCCTTCCCCGACTGTATCGACGGCTCCGACGAGCTCATGTGTGAAATCACCAAGCCGCCCTCAGACGACAGCCCGGCCCA CAGCAGTGCCATCGGGCCCGTCATTGGCATCATCCTCTCTCTCTTCGTCATGGGTGGTGTCTATTTTGTGTGCCAGCGCGTGGTGTGCCA GCGCTATGCGGGGGCCAACGGGCCCTTCCCGCACGAGTATGTCAGCGGGACCCCGCACGTGCCCCTCAATTTCATAGCCCCGGGCGGTTC CCAGCATGGCCCCTTCACAGGCATCGCATGCGGAAAGTCCATGATGAGCTCCGTGAGCCTGATGGGGGGCCGGGGCGGGGTGCCCCTCTA CGACCGGAACCACGTCACAGGGGCCTCGTCCAGCAGCTCGTCCAGCACGAAGGCCACGCTGTACCCGCCGATCCTGAACCCGCCGCCCTC CCCGGCCACGGACCCCTCCCTGTACAACATGGACATGTTCTACTCTTCAAACATTCCGGCCACTGCGAGACCGTACAGGCCCTACATCAT TCGAGGAATGGCGCCCCCGACGACGCCCTGCAGCACCGACGTGTGTGACAGCGACTACAGCGCCAGCCGCTGGAAGGCCAGCAAGTACTA CCTGGATTTGAACTCGGACTCAGACCCCTATCCACCCCCACCCACGCCCCACAGCCAGTACCTGTCGGCGGAGGACAGCTGCCCGCCCTC GCCCGCCACCGAGAGGAGCTACTTCCATCTCTTCCCGCCCCCTCCGTCCCCCTGCACGGACTCATCCTGACCTCGGCCGGGCCACTCTGG CTTCTCTGTGCCCCTGTAAATAGTTTTAAATATGAACAAAGAAAAAAATATATTTTATGATTTAAAAAATAAATATAATTGGGATTTTAA AAACATGAGAAATGTGAACTGTGATGGGGTGGGCAGGGCTGGGAGAACTTTGTACAGTGGAGAAATATTTATAAACTTAATTTTGTAAAA >72123_72123_1_RANGRF-LRP5_RANGRF_chr17_8192732_ENST00000226105_LRP5_chr11_68177382_ENST00000294304_length(amino acids)=1035AA_BP=116 MEPTRDCPLFGGAFSAILPMGAIDVSDLRPVPDNQEVFCHPVTDQSLIVELLELQAHVRGEAAARYHFEDVGGVQGARAVHVESVQPLSL ENLALRGRCQEAWVLSGKQQIAKENQQTISRAFMNGSSVEHVVEFGLDYPEGMAVDWMGKNLYWADTGTNRIEVARLDGQFRQVLVWRDL DNPRSLALDPTKGYIYWTEWGGKPRIVRAFMDGTNCMTLVDKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVVIADDLPHPFG LTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQDGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRN CSPPTTFLLFSQKSAISRMIPDDQHSPDLILPLHGLRNVKAIDYDPLDKFIYWVDGRQNIKRAKDDGTQPFVLTSLSQGQNPDRQPHDLS IDIYSRTLFWTCEATNTINVHRLSGEAMGVVLRGDRDKPRAIVVNAERGYLYFTNMQDRAAKIERAALDGTEREVLFTTGLIRPVALVVD NTLGKLFWVDADLKRIESCDLSGANRLTLEDANIVQPLGLTILGKHLYWIDRQQQMIERVEKTTGDKRTRIQGRVAHLTGIHAVEEVSLE EFSAHPCARDNGGCSHICIAKGDGTPRCSCPVHLVLLQNLLTCGEPPTCSPDQFACATGEIDCIPGAWRCDGFPECDDQSDEEGCPVCSA AQFPCARGQCVDLRLRCDGEADCQDRSDEADCDAICLPNQFRCASGQCVLIKQQCDSFPDCIDGSDELMCEITKPPSDDSPAHSSAIGPV IGIILSLFVMGGVYFVCQRVVCQRYAGANGPFPHEYVSGTPHVPLNFIAPGGSQHGPFTGIACGKSMMSSVSLMGGRGGVPLYDRNHVTG ASSSSSSSTKATLYPPILNPPPSPATDPSLYNMDMFYSSNIPATARPYRPYIIRGMAPPTTPCSTDVCDSDYSASRWKASKYYLDLNSDS -------------------------------------------------------------- >72123_72123_2_RANGRF-LRP5_RANGRF_chr17_8192732_ENST00000407006_LRP5_chr11_68177382_ENST00000294304_length(transcript)=3448nt_BP=486nt AAATCTTAAAGGATCCGGGAGCTAAGCCAGACCCGGGTGGCGGTGGCAGCTGCGAAACCCAGGGAGCCGATGCCACGTGACCCAATGTGG ACTTCTTTTAAACCTTTCTAATGCCCATAACCCAGCCTCAGACCCATGGAGCCCACGAGAGACTGCCCGCTGTTCGGGGGCGCCTTTTCC GCCATCCTCCCCATGGGGGCCATTGACGTAAGCGACCTCCGACCGGTCCCGGACAATCAAGAAGTTTTCTGCCATCCCGTGACGGACCAG AGCCTGATAGTGGAACTTCTCGAGCTGCAGGCCCACGTACGGGGCGAAGCGGCTGCGCGGTACCACTTTGAGGATGTTGGTGGCGTGCAG GGGGCTAGGGCTGTCCATGTGGAGTCTGTTCAGCCTCTCAGTTTGGAGAACCTGGCCCTGAGGGGCCGCTGTCAAGAAGCCTGGGTCCTC TCTGGCAAGCAGCAGATAGCTAAGGAAAACCAGCAGACCATCAGCCGCGCCTTCATGAACGGGAGCTCGGTGGAGCACGTGGTGGAGTTT GGCCTTGACTACCCCGAGGGCATGGCCGTTGACTGGATGGGCAAGAACCTCTACTGGGCCGACACTGGGACCAACAGAATCGAAGTGGCG CGGCTGGACGGGCAGTTCCGGCAAGTCCTCGTGTGGAGGGACTTGGACAACCCGAGGTCGCTGGCCCTGGATCCCACCAAGGGCTACATC TACTGGACCGAGTGGGGCGGCAAGCCGAGGATCGTGCGGGCCTTCATGGACGGGACCAACTGCATGACGCTGGTGGACAAGGTGGGCCGG GCCAACGACCTCACCATTGACTACGCTGACCAGCGCCTCTACTGGACCGACCTGGACACCAACATGATCGAGTCGTCCAACATGCTGGGT CAGGAGCGGGTCGTGATTGCCGACGATCTCCCGCACCCGTTCGGTCTGACGCAGTACAGCGATTATATCTACTGGACAGACTGGAATCTG CACAGCATTGAGCGGGCCGACAAGACTAGCGGCCGGAACCGCACCCTCATCCAGGGCCACCTGGACTTCGTGATGGACATCCTGGTGTTC CACTCCTCCCGCCAGGATGGCCTCAATGACTGTATGCACAACAACGGGCAGTGTGGGCAGCTGTGCCTTGCCATCCCCGGCGGCCACCGC TGCGGCTGCGCCTCACACTACACCCTGGACCCCAGCAGCCGCAACTGCAGCCCGCCCACCACCTTCTTGCTGTTCAGCCAGAAATCTGCC ATCAGTCGGATGATCCCGGACGACCAGCACAGCCCGGATCTCATCCTGCCCCTGCATGGACTGAGGAACGTCAAAGCCATCGACTATGAC CCACTGGACAAGTTCATCTACTGGGTGGATGGGCGCCAGAACATCAAGCGAGCCAAGGACGACGGGACCCAGCCCTTTGTTTTGACCTCT CTGAGCCAAGGCCAAAACCCAGACAGGCAGCCCCACGACCTCAGCATCGACATCTACAGCCGGACACTGTTCTGGACGTGCGAGGCCACC AATACCATCAACGTCCACAGGCTGAGCGGGGAAGCCATGGGGGTGGTGCTGCGTGGGGACCGCGACAAGCCCAGGGCCATCGTCGTCAAC GCGGAGCGAGGGTACCTGTACTTCACCAACATGCAGGACCGGGCAGCCAAGATCGAACGCGCAGCCCTGGACGGCACCGAGCGCGAGGTC CTCTTCACCACCGGCCTCATCCGCCCTGTGGCCCTGGTGGTGGACAACACACTGGGCAAGCTGTTCTGGGTGGACGCGGACCTGAAGCGC ATTGAGAGCTGTGACCTGTCAGGGGCCAACCGCCTGACCCTGGAGGACGCCAACATCGTGCAGCCTCTGGGCCTGACCATCCTTGGCAAG CATCTCTACTGGATCGACCGCCAGCAGCAGATGATCGAGCGTGTGGAGAAGACCACCGGGGACAAGCGGACTCGCATCCAGGGCCGTGTC GCCCACCTCACTGGCATCCATGCAGTGGAGGAAGTCAGCCTGGAGGAGTTCTCAGCCCACCCATGTGCCCGTGACAATGGTGGCTGCTCC CACATCTGTATTGCCAAGGGTGATGGGACACCACGGTGCTCATGCCCAGTCCACCTCGTGCTCCTGCAGAACCTGCTGACCTGTGGAGAG CCGCCCACCTGCTCCCCGGACCAGTTTGCATGTGCCACAGGGGAGATCGACTGTATCCCCGGGGCCTGGCGCTGTGACGGCTTTCCCGAG TGCGATGACCAGAGCGACGAGGAGGGCTGCCCCGTGTGCTCCGCCGCCCAGTTCCCCTGCGCGCGGGGTCAGTGTGTGGACCTGCGCCTG CGCTGCGACGGCGAGGCAGACTGTCAGGACCGCTCAGACGAGGCGGACTGTGACGCCATCTGCCTGCCCAACCAGTTCCGGTGTGCGAGC GGCCAGTGTGTCCTCATCAAACAGCAGTGCGACTCCTTCCCCGACTGTATCGACGGCTCCGACGAGCTCATGTGTGAAATCACCAAGCCG CCCTCAGACGACAGCCCGGCCCACAGCAGTGCCATCGGGCCCGTCATTGGCATCATCCTCTCTCTCTTCGTCATGGGTGGTGTCTATTTT GTGTGCCAGCGCGTGGTGTGCCAGCGCTATGCGGGGGCCAACGGGCCCTTCCCGCACGAGTATGTCAGCGGGACCCCGCACGTGCCCCTC AATTTCATAGCCCCGGGCGGTTCCCAGCATGGCCCCTTCACAGGCATCGCATGCGGAAAGTCCATGATGAGCTCCGTGAGCCTGATGGGG GGCCGGGGCGGGGTGCCCCTCTACGACCGGAACCACGTCACAGGGGCCTCGTCCAGCAGCTCGTCCAGCACGAAGGCCACGCTGTACCCG CCGATCCTGAACCCGCCGCCCTCCCCGGCCACGGACCCCTCCCTGTACAACATGGACATGTTCTACTCTTCAAACATTCCGGCCACTGCG AGACCGTACAGGCCCTACATCATTCGAGGAATGGCGCCCCCGACGACGCCCTGCAGCACCGACGTGTGTGACAGCGACTACAGCGCCAGC CGCTGGAAGGCCAGCAAGTACTACCTGGATTTGAACTCGGACTCAGACCCCTATCCACCCCCACCCACGCCCCACAGCCAGTACCTGTCG GCGGAGGACAGCTGCCCGCCCTCGCCCGCCACCGAGAGGAGCTACTTCCATCTCTTCCCGCCCCCTCCGTCCCCCTGCACGGACTCATCC TGACCTCGGCCGGGCCACTCTGGCTTCTCTGTGCCCCTGTAAATAGTTTTAAATATGAACAAAGAAAAAAATATATTTTATGATTTAAAA AATAAATATAATTGGGATTTTAAAAACATGAGAAATGTGAACTGTGATGGGGTGGGCAGGGCTGGGAGAACTTTGTACAGTGGAGAAATA >72123_72123_2_RANGRF-LRP5_RANGRF_chr17_8192732_ENST00000407006_LRP5_chr11_68177382_ENST00000294304_length(amino acids)=1035AA_BP=116 MEPTRDCPLFGGAFSAILPMGAIDVSDLRPVPDNQEVFCHPVTDQSLIVELLELQAHVRGEAAARYHFEDVGGVQGARAVHVESVQPLSL ENLALRGRCQEAWVLSGKQQIAKENQQTISRAFMNGSSVEHVVEFGLDYPEGMAVDWMGKNLYWADTGTNRIEVARLDGQFRQVLVWRDL DNPRSLALDPTKGYIYWTEWGGKPRIVRAFMDGTNCMTLVDKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVVIADDLPHPFG LTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQDGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRN CSPPTTFLLFSQKSAISRMIPDDQHSPDLILPLHGLRNVKAIDYDPLDKFIYWVDGRQNIKRAKDDGTQPFVLTSLSQGQNPDRQPHDLS IDIYSRTLFWTCEATNTINVHRLSGEAMGVVLRGDRDKPRAIVVNAERGYLYFTNMQDRAAKIERAALDGTEREVLFTTGLIRPVALVVD NTLGKLFWVDADLKRIESCDLSGANRLTLEDANIVQPLGLTILGKHLYWIDRQQQMIERVEKTTGDKRTRIQGRVAHLTGIHAVEEVSLE EFSAHPCARDNGGCSHICIAKGDGTPRCSCPVHLVLLQNLLTCGEPPTCSPDQFACATGEIDCIPGAWRCDGFPECDDQSDEEGCPVCSA AQFPCARGQCVDLRLRCDGEADCQDRSDEADCDAICLPNQFRCASGQCVLIKQQCDSFPDCIDGSDELMCEITKPPSDDSPAHSSAIGPV IGIILSLFVMGGVYFVCQRVVCQRYAGANGPFPHEYVSGTPHVPLNFIAPGGSQHGPFTGIACGKSMMSSVSLMGGRGGVPLYDRNHVTG ASSSSSSSTKATLYPPILNPPPSPATDPSLYNMDMFYSSNIPATARPYRPYIIRGMAPPTTPCSTDVCDSDYSASRWKASKYYLDLNSDS -------------------------------------------------------------- >72123_72123_3_RANGRF-LRP5_RANGRF_chr17_8192732_ENST00000439238_LRP5_chr11_68177382_ENST00000294304_length(transcript)=3945nt_BP=983nt AGCCAGACCCGGGTGGCGGTGGCAGCTGCGAAACCCAGGGAGCCGATGCCACGTGACCCAATGTGGACTTCTTTTAAACCTTTCTAATGC CCATAACCCAGCCTCAGACCCATGGAGCCCACGAGAGACTGCCCGCTGTTCGGGGGCGCCTTTTCCGCCATCCTCCCCATGGGGGCCATT GACGTAAGCGACCTCCGACCGGTCCCGGACAATCAAGAAGTTTTCTGCCATCCCGTGACGGACCAGAGCCTGATAGTGGAACTTCTCGAG CTGCAGGCCCACGTACGGGGCGAAGCGGCTGCGCGGTGAGGGCCCGAGAGTGTGTAATGTCCTGGAAGGGCGGTAGCGGGGACGCAGAGA TCCAGGTAAGCATCCTGACTCTGATCCCCTTAGGTAGCAAAGGACGTGACACTTCATCAGGCCTTGCTGAGGCTGCCCCAGTACCAGACT GATCTCTTGCTTACCTTCAATCAGCCCCCGTAAGGAGGAAGGAACGGGCGGGTATCTCATGACTGGGTTCCCAGGAGAATCGGGCTGGGA GGGACAGAACAGGGAGACTCACTGGTGGGATCCTCCAAGGAAGCAGGAGTGGGCCAGAGGTTTGGGGTAACTGATACCCAGGTCCTCTGG GGAACAGGAATTGGCAATTTCCAAACCTCAGGCCTGGATGATGTTCTGTCTCCATCTGTTCCCCCACCCCAAGCCCTGACAACAGGTCAT CTCTTGGCCCCGAAAATCTGTCACCTGCACCCTGGAGCCTGGGTGACTTTGAACAGCTGGTGACCAGTCTGACCCTTCACGATCCTAACA TCTTTGGTCCCCAGTAAAGGCGCTGAAGCACTGCATGATGTTGCTGAGAACTTGGGGACTCGGTTCTGTGAGGGGGAAAAGAGGTTGAAA AGAGGGTTTCCTCTTATTTCTTCCCTGTGCGTAAACATAAGACAATCCCTCTTCAGAATAAACTTGCTTTATAATCAATATAAACCATCA GCCGCGCCTTCATGAACGGGAGCTCGGTGGAGCACGTGGTGGAGTTTGGCCTTGACTACCCCGAGGGCATGGCCGTTGACTGGATGGGCA AGAACCTCTACTGGGCCGACACTGGGACCAACAGAATCGAAGTGGCGCGGCTGGACGGGCAGTTCCGGCAAGTCCTCGTGTGGAGGGACT TGGACAACCCGAGGTCGCTGGCCCTGGATCCCACCAAGGGCTACATCTACTGGACCGAGTGGGGCGGCAAGCCGAGGATCGTGCGGGCCT TCATGGACGGGACCAACTGCATGACGCTGGTGGACAAGGTGGGCCGGGCCAACGACCTCACCATTGACTACGCTGACCAGCGCCTCTACT GGACCGACCTGGACACCAACATGATCGAGTCGTCCAACATGCTGGGTCAGGAGCGGGTCGTGATTGCCGACGATCTCCCGCACCCGTTCG GTCTGACGCAGTACAGCGATTATATCTACTGGACAGACTGGAATCTGCACAGCATTGAGCGGGCCGACAAGACTAGCGGCCGGAACCGCA CCCTCATCCAGGGCCACCTGGACTTCGTGATGGACATCCTGGTGTTCCACTCCTCCCGCCAGGATGGCCTCAATGACTGTATGCACAACA ACGGGCAGTGTGGGCAGCTGTGCCTTGCCATCCCCGGCGGCCACCGCTGCGGCTGCGCCTCACACTACACCCTGGACCCCAGCAGCCGCA ACTGCAGCCCGCCCACCACCTTCTTGCTGTTCAGCCAGAAATCTGCCATCAGTCGGATGATCCCGGACGACCAGCACAGCCCGGATCTCA TCCTGCCCCTGCATGGACTGAGGAACGTCAAAGCCATCGACTATGACCCACTGGACAAGTTCATCTACTGGGTGGATGGGCGCCAGAACA TCAAGCGAGCCAAGGACGACGGGACCCAGCCCTTTGTTTTGACCTCTCTGAGCCAAGGCCAAAACCCAGACAGGCAGCCCCACGACCTCA GCATCGACATCTACAGCCGGACACTGTTCTGGACGTGCGAGGCCACCAATACCATCAACGTCCACAGGCTGAGCGGGGAAGCCATGGGGG TGGTGCTGCGTGGGGACCGCGACAAGCCCAGGGCCATCGTCGTCAACGCGGAGCGAGGGTACCTGTACTTCACCAACATGCAGGACCGGG CAGCCAAGATCGAACGCGCAGCCCTGGACGGCACCGAGCGCGAGGTCCTCTTCACCACCGGCCTCATCCGCCCTGTGGCCCTGGTGGTGG ACAACACACTGGGCAAGCTGTTCTGGGTGGACGCGGACCTGAAGCGCATTGAGAGCTGTGACCTGTCAGGGGCCAACCGCCTGACCCTGG AGGACGCCAACATCGTGCAGCCTCTGGGCCTGACCATCCTTGGCAAGCATCTCTACTGGATCGACCGCCAGCAGCAGATGATCGAGCGTG TGGAGAAGACCACCGGGGACAAGCGGACTCGCATCCAGGGCCGTGTCGCCCACCTCACTGGCATCCATGCAGTGGAGGAAGTCAGCCTGG AGGAGTTCTCAGCCCACCCATGTGCCCGTGACAATGGTGGCTGCTCCCACATCTGTATTGCCAAGGGTGATGGGACACCACGGTGCTCAT GCCCAGTCCACCTCGTGCTCCTGCAGAACCTGCTGACCTGTGGAGAGCCGCCCACCTGCTCCCCGGACCAGTTTGCATGTGCCACAGGGG AGATCGACTGTATCCCCGGGGCCTGGCGCTGTGACGGCTTTCCCGAGTGCGATGACCAGAGCGACGAGGAGGGCTGCCCCGTGTGCTCCG CCGCCCAGTTCCCCTGCGCGCGGGGTCAGTGTGTGGACCTGCGCCTGCGCTGCGACGGCGAGGCAGACTGTCAGGACCGCTCAGACGAGG CGGACTGTGACGCCATCTGCCTGCCCAACCAGTTCCGGTGTGCGAGCGGCCAGTGTGTCCTCATCAAACAGCAGTGCGACTCCTTCCCCG ACTGTATCGACGGCTCCGACGAGCTCATGTGTGAAATCACCAAGCCGCCCTCAGACGACAGCCCGGCCCACAGCAGTGCCATCGGGCCCG TCATTGGCATCATCCTCTCTCTCTTCGTCATGGGTGGTGTCTATTTTGTGTGCCAGCGCGTGGTGTGCCAGCGCTATGCGGGGGCCAACG GGCCCTTCCCGCACGAGTATGTCAGCGGGACCCCGCACGTGCCCCTCAATTTCATAGCCCCGGGCGGTTCCCAGCATGGCCCCTTCACAG GCATCGCATGCGGAAAGTCCATGATGAGCTCCGTGAGCCTGATGGGGGGCCGGGGCGGGGTGCCCCTCTACGACCGGAACCACGTCACAG GGGCCTCGTCCAGCAGCTCGTCCAGCACGAAGGCCACGCTGTACCCGCCGATCCTGAACCCGCCGCCCTCCCCGGCCACGGACCCCTCCC TGTACAACATGGACATGTTCTACTCTTCAAACATTCCGGCCACTGCGAGACCGTACAGGCCCTACATCATTCGAGGAATGGCGCCCCCGA CGACGCCCTGCAGCACCGACGTGTGTGACAGCGACTACAGCGCCAGCCGCTGGAAGGCCAGCAAGTACTACCTGGATTTGAACTCGGACT CAGACCCCTATCCACCCCCACCCACGCCCCACAGCCAGTACCTGTCGGCGGAGGACAGCTGCCCGCCCTCGCCCGCCACCGAGAGGAGCT ACTTCCATCTCTTCCCGCCCCCTCCGTCCCCCTGCACGGACTCATCCTGACCTCGGCCGGGCCACTCTGGCTTCTCTGTGCCCCTGTAAA TAGTTTTAAATATGAACAAAGAAAAAAATATATTTTATGATTTAAAAAATAAATATAATTGGGATTTTAAAAACATGAGAAATGTGAACT >72123_72123_3_RANGRF-LRP5_RANGRF_chr17_8192732_ENST00000439238_LRP5_chr11_68177382_ENST00000294304_length(amino acids)=912AA_BP= MNGSSVEHVVEFGLDYPEGMAVDWMGKNLYWADTGTNRIEVARLDGQFRQVLVWRDLDNPRSLALDPTKGYIYWTEWGGKPRIVRAFMDG TNCMTLVDKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVVIADDLPHPFGLTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQ GHLDFVMDILVFHSSRQDGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRNCSPPTTFLLFSQKSAISRMIPDDQHSPDLILPL HGLRNVKAIDYDPLDKFIYWVDGRQNIKRAKDDGTQPFVLTSLSQGQNPDRQPHDLSIDIYSRTLFWTCEATNTINVHRLSGEAMGVVLR GDRDKPRAIVVNAERGYLYFTNMQDRAAKIERAALDGTEREVLFTTGLIRPVALVVDNTLGKLFWVDADLKRIESCDLSGANRLTLEDAN IVQPLGLTILGKHLYWIDRQQQMIERVEKTTGDKRTRIQGRVAHLTGIHAVEEVSLEEFSAHPCARDNGGCSHICIAKGDGTPRCSCPVH LVLLQNLLTCGEPPTCSPDQFACATGEIDCIPGAWRCDGFPECDDQSDEEGCPVCSAAQFPCARGQCVDLRLRCDGEADCQDRSDEADCD AICLPNQFRCASGQCVLIKQQCDSFPDCIDGSDELMCEITKPPSDDSPAHSSAIGPVIGIILSLFVMGGVYFVCQRVVCQRYAGANGPFP HEYVSGTPHVPLNFIAPGGSQHGPFTGIACGKSMMSSVSLMGGRGGVPLYDRNHVTGASSSSSSSTKATLYPPILNPPPSPATDPSLYNM DMFYSSNIPATARPYRPYIIRGMAPPTTPCSTDVCDSDYSASRWKASKYYLDLNSDSDPYPPPPTPHSQYLSAEDSCPPSPATERSYFHL -------------------------------------------------------------- >72123_72123_4_RANGRF-LRP5_RANGRF_chr17_8192732_ENST00000580434_LRP5_chr11_68177382_ENST00000294304_length(transcript)=3431nt_BP=469nt GGAGCTAAGCCAGACCCGGGTGGCGGTGGCAGCTGCGAAACCCAGGGAGCCGATGCCACGTGACCCAATGTGGACTTCTTTTAAACCTTT CTAATGCCCATAACCCAGCCTCAGACCCATGGAGCCCACGAGAGACTGCCCGCTGTTCGGGGGCGCCTTTTCCGCCATCCTCCCCATGGG GGCCATTGACGTAAGCGACCTCCGACCGGTCCCGGACAATCAAGAAGTTTTCTGCCATCCCGTGACGGACCAGAGCCTGATAGTGGAACT TCTCGAGCTGCAGGCCCACGTACGGGGCGAAGCGGCTGCGCGGTACCACTTTGAGGATGTTGGTGGCGTGCAGGGGGCTAGGGCTGTCCA TGTGGAGTCTGTTCAGCCTCTCAGTTTGGAGAACCTGGCCCTGAGGGGCCGCTGTCAAGAAGCCTGGGTCCTCTCTGGCAAGCAGCAGAT AGCTAAGGAAAACCAGCAGACCATCAGCCGCGCCTTCATGAACGGGAGCTCGGTGGAGCACGTGGTGGAGTTTGGCCTTGACTACCCCGA GGGCATGGCCGTTGACTGGATGGGCAAGAACCTCTACTGGGCCGACACTGGGACCAACAGAATCGAAGTGGCGCGGCTGGACGGGCAGTT CCGGCAAGTCCTCGTGTGGAGGGACTTGGACAACCCGAGGTCGCTGGCCCTGGATCCCACCAAGGGCTACATCTACTGGACCGAGTGGGG CGGCAAGCCGAGGATCGTGCGGGCCTTCATGGACGGGACCAACTGCATGACGCTGGTGGACAAGGTGGGCCGGGCCAACGACCTCACCAT TGACTACGCTGACCAGCGCCTCTACTGGACCGACCTGGACACCAACATGATCGAGTCGTCCAACATGCTGGGTCAGGAGCGGGTCGTGAT TGCCGACGATCTCCCGCACCCGTTCGGTCTGACGCAGTACAGCGATTATATCTACTGGACAGACTGGAATCTGCACAGCATTGAGCGGGC CGACAAGACTAGCGGCCGGAACCGCACCCTCATCCAGGGCCACCTGGACTTCGTGATGGACATCCTGGTGTTCCACTCCTCCCGCCAGGA TGGCCTCAATGACTGTATGCACAACAACGGGCAGTGTGGGCAGCTGTGCCTTGCCATCCCCGGCGGCCACCGCTGCGGCTGCGCCTCACA CTACACCCTGGACCCCAGCAGCCGCAACTGCAGCCCGCCCACCACCTTCTTGCTGTTCAGCCAGAAATCTGCCATCAGTCGGATGATCCC GGACGACCAGCACAGCCCGGATCTCATCCTGCCCCTGCATGGACTGAGGAACGTCAAAGCCATCGACTATGACCCACTGGACAAGTTCAT CTACTGGGTGGATGGGCGCCAGAACATCAAGCGAGCCAAGGACGACGGGACCCAGCCCTTTGTTTTGACCTCTCTGAGCCAAGGCCAAAA CCCAGACAGGCAGCCCCACGACCTCAGCATCGACATCTACAGCCGGACACTGTTCTGGACGTGCGAGGCCACCAATACCATCAACGTCCA CAGGCTGAGCGGGGAAGCCATGGGGGTGGTGCTGCGTGGGGACCGCGACAAGCCCAGGGCCATCGTCGTCAACGCGGAGCGAGGGTACCT GTACTTCACCAACATGCAGGACCGGGCAGCCAAGATCGAACGCGCAGCCCTGGACGGCACCGAGCGCGAGGTCCTCTTCACCACCGGCCT CATCCGCCCTGTGGCCCTGGTGGTGGACAACACACTGGGCAAGCTGTTCTGGGTGGACGCGGACCTGAAGCGCATTGAGAGCTGTGACCT GTCAGGGGCCAACCGCCTGACCCTGGAGGACGCCAACATCGTGCAGCCTCTGGGCCTGACCATCCTTGGCAAGCATCTCTACTGGATCGA CCGCCAGCAGCAGATGATCGAGCGTGTGGAGAAGACCACCGGGGACAAGCGGACTCGCATCCAGGGCCGTGTCGCCCACCTCACTGGCAT CCATGCAGTGGAGGAAGTCAGCCTGGAGGAGTTCTCAGCCCACCCATGTGCCCGTGACAATGGTGGCTGCTCCCACATCTGTATTGCCAA GGGTGATGGGACACCACGGTGCTCATGCCCAGTCCACCTCGTGCTCCTGCAGAACCTGCTGACCTGTGGAGAGCCGCCCACCTGCTCCCC GGACCAGTTTGCATGTGCCACAGGGGAGATCGACTGTATCCCCGGGGCCTGGCGCTGTGACGGCTTTCCCGAGTGCGATGACCAGAGCGA CGAGGAGGGCTGCCCCGTGTGCTCCGCCGCCCAGTTCCCCTGCGCGCGGGGTCAGTGTGTGGACCTGCGCCTGCGCTGCGACGGCGAGGC AGACTGTCAGGACCGCTCAGACGAGGCGGACTGTGACGCCATCTGCCTGCCCAACCAGTTCCGGTGTGCGAGCGGCCAGTGTGTCCTCAT CAAACAGCAGTGCGACTCCTTCCCCGACTGTATCGACGGCTCCGACGAGCTCATGTGTGAAATCACCAAGCCGCCCTCAGACGACAGCCC GGCCCACAGCAGTGCCATCGGGCCCGTCATTGGCATCATCCTCTCTCTCTTCGTCATGGGTGGTGTCTATTTTGTGTGCCAGCGCGTGGT GTGCCAGCGCTATGCGGGGGCCAACGGGCCCTTCCCGCACGAGTATGTCAGCGGGACCCCGCACGTGCCCCTCAATTTCATAGCCCCGGG CGGTTCCCAGCATGGCCCCTTCACAGGCATCGCATGCGGAAAGTCCATGATGAGCTCCGTGAGCCTGATGGGGGGCCGGGGCGGGGTGCC CCTCTACGACCGGAACCACGTCACAGGGGCCTCGTCCAGCAGCTCGTCCAGCACGAAGGCCACGCTGTACCCGCCGATCCTGAACCCGCC GCCCTCCCCGGCCACGGACCCCTCCCTGTACAACATGGACATGTTCTACTCTTCAAACATTCCGGCCACTGCGAGACCGTACAGGCCCTA CATCATTCGAGGAATGGCGCCCCCGACGACGCCCTGCAGCACCGACGTGTGTGACAGCGACTACAGCGCCAGCCGCTGGAAGGCCAGCAA GTACTACCTGGATTTGAACTCGGACTCAGACCCCTATCCACCCCCACCCACGCCCCACAGCCAGTACCTGTCGGCGGAGGACAGCTGCCC GCCCTCGCCCGCCACCGAGAGGAGCTACTTCCATCTCTTCCCGCCCCCTCCGTCCCCCTGCACGGACTCATCCTGACCTCGGCCGGGCCA CTCTGGCTTCTCTGTGCCCCTGTAAATAGTTTTAAATATGAACAAAGAAAAAAATATATTTTATGATTTAAAAAATAAATATAATTGGGA TTTTAAAAACATGAGAAATGTGAACTGTGATGGGGTGGGCAGGGCTGGGAGAACTTTGTACAGTGGAGAAATATTTATAAACTTAATTTT >72123_72123_4_RANGRF-LRP5_RANGRF_chr17_8192732_ENST00000580434_LRP5_chr11_68177382_ENST00000294304_length(amino acids)=1035AA_BP=116 MEPTRDCPLFGGAFSAILPMGAIDVSDLRPVPDNQEVFCHPVTDQSLIVELLELQAHVRGEAAARYHFEDVGGVQGARAVHVESVQPLSL ENLALRGRCQEAWVLSGKQQIAKENQQTISRAFMNGSSVEHVVEFGLDYPEGMAVDWMGKNLYWADTGTNRIEVARLDGQFRQVLVWRDL DNPRSLALDPTKGYIYWTEWGGKPRIVRAFMDGTNCMTLVDKVGRANDLTIDYADQRLYWTDLDTNMIESSNMLGQERVVIADDLPHPFG LTQYSDYIYWTDWNLHSIERADKTSGRNRTLIQGHLDFVMDILVFHSSRQDGLNDCMHNNGQCGQLCLAIPGGHRCGCASHYTLDPSSRN CSPPTTFLLFSQKSAISRMIPDDQHSPDLILPLHGLRNVKAIDYDPLDKFIYWVDGRQNIKRAKDDGTQPFVLTSLSQGQNPDRQPHDLS IDIYSRTLFWTCEATNTINVHRLSGEAMGVVLRGDRDKPRAIVVNAERGYLYFTNMQDRAAKIERAALDGTEREVLFTTGLIRPVALVVD NTLGKLFWVDADLKRIESCDLSGANRLTLEDANIVQPLGLTILGKHLYWIDRQQQMIERVEKTTGDKRTRIQGRVAHLTGIHAVEEVSLE EFSAHPCARDNGGCSHICIAKGDGTPRCSCPVHLVLLQNLLTCGEPPTCSPDQFACATGEIDCIPGAWRCDGFPECDDQSDEEGCPVCSA AQFPCARGQCVDLRLRCDGEADCQDRSDEADCDAICLPNQFRCASGQCVLIKQQCDSFPDCIDGSDELMCEITKPPSDDSPAHSSAIGPV IGIILSLFVMGGVYFVCQRVVCQRYAGANGPFPHEYVSGTPHVPLNFIAPGGSQHGPFTGIACGKSMMSSVSLMGGRGGVPLYDRNHVTG ASSSSSSSTKATLYPPILNPPPSPATDPSLYNMDMFYSSNIPATARPYRPYIIRGMAPPTTPCSTDVCDSDYSASRWKASKYYLDLNSDS -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for RANGRF-LRP5 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Hgene | RANGRF | chr17:8192732 | chr11:68177382 | ENST00000226105 | + | 3 | 5 | 27_70 | 117.0 | 187.0 | RAN |
Hgene | RANGRF | chr17:8192732 | chr11:68177382 | ENST00000407006 | + | 3 | 4 | 27_70 | 117.0 | 147.0 | RAN |
Hgene | RANGRF | chr17:8192732 | chr11:68177382 | ENST00000580434 | + | 3 | 4 | 27_70 | 117.0 | 119.0 | RAN |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | RANGRF | chr17:8192732 | chr11:68177382 | ENST00000439238 | + | 1 | 3 | 27_70 | 0 | 166.0 | RAN |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for RANGRF-LRP5 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for RANGRF-LRP5 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | RANGRF | C1142166 | Brugada Syndrome (disorder) | 6 | CLINGEN;ORPHANET |
Hgene | RANGRF | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Tgene | C1866176 | EXUDATIVE VITREORETINOPATHY 4 (disorder) | 10 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0432252 | Osteoporosis with pseudoglioma | 8 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C1866079 | BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1 | 6 | GENOMICS_ENGLAND;UNIPROT | |
Tgene | C1843330 | OSTEOPETROSIS, AUTOSOMAL DOMINANT 1 | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C4693479 | POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS | 3 | GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0432273 | Worth disease | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT | |
Tgene | C1843323 | Van Buchem disease type 2 | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0015397 | Disorder of eye | 1 | GENOMICS_ENGLAND | |
Tgene | C0035344 | Retinopathy of Prematurity | 1 | ORPHANET | |
Tgene | C0151879 | Shortened QT interval | 1 | GENOMICS_ENGLAND | |
Tgene | C0158683 | Polycystic liver disease | 1 | ORPHANET | |
Tgene | C0242852 | Proliferative vitreoretinopathy | 1 | CTD_human | |
Tgene | C0339539 | Familial Exudative Vitreoretinopathy | 1 | CTD_human | |
Tgene | C0432272 | Van Buchem disease | 1 | ORPHANET | |
Tgene | C1851402 | Exudative vitreoretinopathy 1 | 1 | CTD_human;UNIPROT |